How Much Weight Can You Lose on GLP-1 Drugs?

By John Linares, Medical Author | Prime Path Wellness

One of the first questions people ask when considering GLP-1 medications is: how much weight can I actually expect to lose? It's a completely understandable question — and the answer, grounded in clinical research, is more encouraging than most people expect. At Prime Path Wellness (primepathclinic.com), we believe in giving patients realistic, evidence-based expectations so they can plan for a successful and sustainable weight loss journey with GLP-1 therapy.

What the Clinical Trials Actually Show

The weight loss results from GLP-1 clinical trials are unprecedented in the history of pharmaceutical obesity treatment. The STEP 1 trial, which tested semaglutide 2.4 mg (Wegovy) in adults without diabetes, showed that participants lost an average of 14.9% of their body weight over 68 weeks. When we apply this to real numbers: a person starting at 250 pounds could expect to lose approximately 37 pounds on semaglutide. But results don't stop there. Tirzepatide (Zepbound/Mounjaro), which acts on both GLP-1 and GIP receptors, has delivered even more impressive results. In the SURMOUNT-1 trial, participants on the highest dose (15 mg) lost an average of 22.5% of their body weight — equivalent to about 56 pounds for a 250-pound person. These are results previously only seen with bariatric surgery.

Average Weight Loss by Medication

Different GLP-1 medications produce different levels of weight loss, and understanding this helps set appropriate expectations. Semaglutide (Wegovy) at 2.4 mg per week produces an average of 15–17% body weight reduction. Tirzepatide (Zepbound) at 15 mg per week achieves 20–22.5% body weight reduction on average. Liraglutide (Saxenda), an older once-daily GLP-1 medication, produces more modest results — typically 5–8% body weight reduction. Oral semaglutide (Rybelsus) was primarily studied for diabetes, but weight loss of 5–10% has been observed. It's important to understand that these are averages from large clinical trials. Individual results vary based on starting weight, metabolic factors, adherence to the dosing schedule, dietary habits, and physical activity levels.

The Timeline: When Will You See Results?

GLP-1 medications are typically started at a low dose and gradually increased over several weeks to minimize side effects. This gradual dose escalation means that significant weight loss may take a few months to become apparent. In the first 4 weeks, most patients notice reduced appetite and early weight loss of 1–5 pounds. By weeks 8–12, as the dose increases, weight loss typically accelerates to 1–2 pounds per week. By months 3–6, many patients have lost 5–10% of their starting weight. The most significant total weight loss typically occurs between months 6–16 of treatment. Maximum weight loss is generally achieved around 12–18 months of treatment. Importantly, the dose escalation schedule is not a one-size-fits-all approach. At Prime Path Wellness (primepathclinic.com), our providers tailor dosing to each patient's tolerance and response, sometimes slowing the escalation to minimize nausea and other side effects.

Factors That Influence Your Individual Results

While clinical trial averages provide a useful benchmark, your individual results with GLP-1 weight loss therapy will depend on several factors. Starting weight and BMI play a role — those with higher starting weights often lose more total pounds, though the percentage of body weight lost tends to be similar. Metabolic health matters too. Individuals with type 2 diabetes tend to lose slightly less weight on GLP-1 medications than those without diabetes, though they still experience significant improvements. Adherence to the full prescribed dose is critical. Patients who tolerate and maintain the maximum dose consistently achieve the best results. Dietary quality significantly amplifies results. A protein-rich, reduced-calorie diet alongside GLP-1 therapy can dramatically improve outcomes. Physical activity, especially resistance training, helps preserve lean muscle mass during weight loss, improving body composition beyond the scale. Sleep quality and stress management also play underappreciated roles in metabolic regulation and can influence weight loss on GLP-1 medications.

What About People Who Don't Respond as Well?

Not everyone achieves the trial average with GLP-1 medications. Research suggests that approximately 15–20% of patients are "low responders" — losing less than 5% of body weight. If this occurs, healthcare providers typically evaluate whether the patient is at the optimal dose, whether adherence is consistent, and whether other factors (medications, hormonal imbalances, thyroid issues) are affecting results. Switching between GLP-1 medications, or adding adjunct therapies, may improve outcomes for low responders. At Prime Path Wellness, our team closely monitors each patient's progress and adjusts treatment plans accordingly. We don't believe in a set-it-and-forget-it approach to GLP-1 therapy — regular follow-ups and data-driven adjustments are central to our care model.

Weight Loss Maintenance: The Key Challenge

Achieving weight loss is one challenge; maintaining it is another. Studies on GLP-1 medications consistently show that weight regain occurs when treatment is discontinued. The STEP 4 withdrawal trial demonstrated that patients who stopped semaglutide regained approximately two-thirds of their lost weight within 12 months. This underscores an important truth: obesity is a chronic disease with a strong biological basis, and treatment may need to be long-term — just like treatment for hypertension or high cholesterol. For patients who do discontinue GLP-1 therapy, the period during active treatment should be used to build lasting lifestyle habits: establishing healthy eating patterns, developing a consistent exercise routine, and addressing psychological relationships with food. These habits provide a foundation that can help slow weight regain after stopping medication.

Beyond the Scale: Non-Scale Victories

When evaluating GLP-1 medication results, it's important not to focus solely on the number on the scale. Patients report a wide range of non-scale victories that dramatically improve quality of life. These include improved blood sugar control and A1C levels, reduced blood pressure, better cholesterol profiles, decreased joint pain and improved mobility, reduced sleep apnea severity, increased energy levels and physical stamina, improved mental health and self-confidence, and in many cases, reduced need for other medications like blood pressure drugs or diabetes medications. At Prime Path Wellness (primepathclinic.com), we track a full range of health markers — not just weight — to give patients a comprehensive picture of their progress and motivate them during plateaus.

Realistic Expectations Lead to Better Outcomes

Setting realistic expectations is foundational to success with GLP-1 therapy. Patients who expect to lose 50% of their body weight in three months are likely to become discouraged, even if they're achieving medically significant results. Conversely, patients who understand the gradual, steady nature of GLP-1 weight loss tend to be more satisfied, more adherent, and ultimately more successful. At Prime Path Wellness, we take time with every patient to walk through what they can expect based on their individual starting point, the medication prescribed, and their lifestyle factors. We set milestone goals — not just end goals — so every step of progress feels meaningful. If you're ready to understand what GLP-1 therapy could realistically achieve for you personally, we invite you to visit primepathclinic.com and schedule a consultation with John Linares and our experienced medical team.

Disclaimer: This blog is for informational purposes only and does not constitute medical advice. Individual results vary. Consult a qualified healthcare provider before starting any weight loss medication.